U.S. stocks were lower, with the Dow Jones index falling over 1,200 points on Thursday. Shares of Lamb Weston Holdings, Inc. LW rose sharply during Thursday's session after the company reported ...

Biotech companies create drugs from living organisms, requiring a BLA for FDA approval. Pharma companies develop drugs from chemicals, needing an NDA for FDA approval. Many firms blend biotech and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In this dynamic environment, identifying small-cap stocks like Anbio Biotechnology that possess strong growth potential and innovative capabilities can offer intriguing opportunities for investors ...

No sector is left unchanged by the power of AI and digital modeling, and Biotech is no exception. This is because biology is by far the most “messy” of hard sciences. Chemistry or physics can deal ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

The downsizing is planned for May 12. — Cargo Therapeutics, 84 layoffs in San Carlos. The biotech company is halting development and is closing its San Carlos site. The downsizing is planned for ...

Alcon's acquisition of Aurion Biotech enhances its cell therapy capabilities for eye diseases, with Aurion operating independently under Alcon's support. Aurion's AURN001, an allogeneic cell therapy ...

Artificial intelligence (AI) has taken the biotech industry by storm, allowing companies to speed up the drug discovery process while also making it more cost-effective. With so many companies in the ...

CINCINNATI (Cincinnati Business Courier) - A growing biotech and pharmaceuticals manufacturer that announced a large investment in Greater Cincinnati a little over a year ago has unveiled new ...

There remains much uncertainty about these measures, however. As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative news.